Presentation ACC 2016 Optimal Loading Dose and Delivery of P2Y12 Inhibitors: Should the Loading Dose Be Crushed? Presenter: Dominick Angiolillo April 03, 2016 REGISTER for free or LOG IN to view this content Coronary Presentation ACC 2016 Up Next Presentation Sex Differences in Stable Outpatients With Suspected CAD Presenter: Kshipra Hemal April 03, 2016 More slides + Presentation ACC 2016 3-Year Results From the CoreValve US Pivotal High Risk Randomized Trial Comparing Self-Expanding Transcatheter and Surgical Aortic Valves Presenter: Michael Deeb April 03, 2016 Presentation ACC 2016 Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial Presenter: Gregg W. Stone April 03, 2016 We Recommend
Presentation Sex Differences in Stable Outpatients With Suspected CAD Presenter: Kshipra Hemal April 03, 2016
Presentation ACC 2016 3-Year Results From the CoreValve US Pivotal High Risk Randomized Trial Comparing Self-Expanding Transcatheter and Surgical Aortic Valves Presenter: Michael Deeb April 03, 2016
Presentation ACC 2016 Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial Presenter: Gregg W. Stone April 03, 2016